To reauthorize the Kay Hagan Tick Act, and for other purposes.
Latest Action
Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 463.
Official Summary
This bill reauthorizes through FY2030 activities of the Centers for Disease Control and Prevention to address vector-borne diseases (e.g., diseases spread by bites from ticks or mosquitoes). These activities include (1) a national strategy, (2) grants for regional centers of excellence, and (3) cooperative agreements with state, local, and tribal health departments to increase capacity for preventing and responding to vector-borne diseases.
GovScope Watchdog™
AI Government Intelligence™This bill reauthorizes funding and activities through fiscal year 2030 for the Centers for Disease Control and Prevention (CDC) to address vector-borne diseases, which are illnesses transmitted by vectors such as ticks and mosquitoes. The reauthorization supports a national strategy, provides grants to regional centers of excellence, and establishes cooperative agreements with state, local, and tribal health departments to enhance their capacity for prevention and response efforts related to these diseases.
The bill extends CDC efforts to combat vector-borne diseases by funding strategic initiatives and partnerships through 2030, aiming to improve public health preparedness and response.
- Reauthorizes CDC activities focused on vector-borne diseases through FY2030.
- Supports a national strategy to address diseases spread by ticks, mosquitoes, and other vectors.
- Provides grants to regional centers of excellence and cooperative agreements with health departments at various government levels.
['Centers for Disease Control and Prevention (CDC)', 'State, local, and tribal health departments', 'Regional centers of excellence focused on vector-borne diseases', 'Populations at risk of vector-borne diseases']
['Implementation depends on sustained funding and effective coordination among federal, state, local, and tribal entities.', 'Oversight mechanisms for grant distribution and cooperative agreements are not detailed in the summary.', 'Potential challenges in measuring the effectiveness of funded programs and strategies.']
The bill is part of ongoing federal efforts to address public health threats posed by vector-borne diseases. It has passed the House and is currently under consideration in the Senate, reflecting bipartisan recognition of the importance of disease prevention and control. The reauthorization continues previous legislative actions related to the Kay Hagan Tick Act.
Hidden impact flags detected: 1
GovScope reviewed 1 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['Improved capacity at state, local, and tribal health departments may enhance overall public health infrastructure beyond vector-borne diseases.', 'Regional centers of excellence could foster research and innovation in disease prevention strategies.', 'Increased federal coordination may lead to better data collection and sharing on vector-borne disease trends.']
The bill's transparency and oversight provisions related to grant funding and cooperative agreements should be monitored to ensure effective use of resources. Tracking the implementation progress and outcomes of the national strategy will be important for assessing the bill's impact on public health.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.